Accelerate Diagnostics AXDX Stock
Accelerate Diagnostics Price Chart
Accelerate Diagnostics AXDX Financial and Trading Overview
| Accelerate Diagnostics stock price | 0.89 USD |
| Previous Close | 0.77 USD |
| Open | 0.85 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 0.74 - 0.85 USD |
| 52 Week Range | 0.45 - 3.74 USD |
| Volume | 382.49K USD |
| Avg. Volume | 265.37K USD |
| Market Cap | 79.17M USD |
| Beta (5Y Monthly) | 1.192957 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.94 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.9 USD |
AXDX Valuation Measures
| Enterprise Value | 125.02M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.9825 |
| PEG Ratio (5 yr expected) | -0.05 |
| Price/Sales (ttm) | 6.280056 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 9.917 |
| Enterprise Value/EBITDA | -2.091 |
Trading Information
Accelerate Diagnostics Stock Price History
| Beta (5Y Monthly) | 1.192957 |
| 52-Week Change | -9.19% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.74 USD |
| 52 Week Low | 0.45 USD |
| 50-Day Moving Average | 0.76 USD |
| 200-Day Moving Average | 0.92 USD |
AXDX Share Statistics
| Avg. Volume (3 month) | 265.37K USD |
| Avg. Daily Volume (10-Days) | 335.23K USD |
| Shares Outstanding | 99.83M |
| Float | 70.7M |
| Short Ratio | 25.48 |
| % Held by Insiders | 26.71% |
| % Held by Institutions | 27.99% |
| Shares Short | 4.33M |
| Short % of Float | 6.08% |
| Short % of Shares Outstanding | 4.33% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -499.54% |
| Gross Margin | 27.86% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -64.86% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 12.61M USD |
| Revenue Per Share (ttm) | 0.14 USD |
| Quarterly Revenue Growth (yoy) | -4.90% |
| Gross Profit (ttm) | 3.3M USD |
| EBITDA | -59786000 USD |
| Net Income Avi to Common (ttm) | -65823000 USD |
| Diluted EPS (ttm) | -0.56 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 31.87M USD |
| Total Cash Per Share (mrq) | 0.32 USD |
| Total Debt (mrq) | 78.03M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.629 |
| Book Value Per Share (mrq) | -0.389 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -49489000 USD |
| Levered Free Cash Flow (ttm) | -26923624 USD |
Profile of Accelerate Diagnostics
| Country | United States |
| State | AZ |
| City | Tucson |
| Address | 3950 South Country Club Road |
| ZIP | 85714 |
| Phone | 520 365 3100 |
| Website | https://acceleratediagnostics.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 179 |
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. The company was incorporated in 1982 and is headquartered in Tucson, Arizona.
Q&A For Accelerate Diagnostics Stock
What is a current AXDX stock price?
Accelerate Diagnostics AXDX stock price today per share is 0.89 USD.
How to purchase Accelerate Diagnostics stock?
You can buy AXDX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Accelerate Diagnostics?
The stock symbol or ticker of Accelerate Diagnostics is AXDX.
Which industry does the Accelerate Diagnostics company belong to?
The Accelerate Diagnostics industry is Medical Devices.
How many shares does Accelerate Diagnostics have in circulation?
The max supply of Accelerate Diagnostics shares is 21.66M.
What is Accelerate Diagnostics Price to Earnings Ratio (PE Ratio)?
Accelerate Diagnostics PE Ratio is now.
What was Accelerate Diagnostics earnings per share over the trailing 12 months (TTM)?
Accelerate Diagnostics EPS is -4.94 USD over the trailing 12 months.
Which sector does the Accelerate Diagnostics company belong to?
The Accelerate Diagnostics sector is Healthcare.
Accelerate Diagnostics AXDX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Capital Market Composite RCMP | 114.55 USD — |
-2.27
|
— — | 114.09 USD — | 116.72 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
- {{ link.label }} {{link}}